Literature DB >> 7388116

Schizophrenia: a biochemical disorder?

D F Horrobin.   

Abstract

There is evidence that schizophrenia may be related to excess biological activity of dopamine, deficient synthesis of a prostaglandin and to the presence of a normal opioid in excess or of an abnormal opioid. These three groups of observations seem to be interrelated since opioids are able to inhibit the formation of prostaglandin E1 and prostaglandin E1 and dopamine inhibit each other's effects. A low prostaglandin E1 level will therefore produce and apparent dopamine excess. Niacin causes flushing, apparently by stimulating production of prostaglandin E1. Much larger doses of oral niacin are required to produce flushing in schizophrenics than in normal individuals. Most schizophrenics do not flush when given 250 mg orally and this may be a simple biochemically-based test for a major group of schizophrenics.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7388116

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  8 in total

1.  Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives.

Authors:  Sheng-Hsiang Lin; Chih-Min Liu; Shu-Sen Chang; Hai-Gwo Hwu; Shi K Liu; Tzung J Hwang; Ming-Hsien Hsieh; Shi-Chin Guo; Wei J Chen
Journal:  Schizophr Bull       Date:  2006-08-25       Impact factor: 9.306

2.  Artificial intelligence-assisted niacin skin flush screening in early psychosis identification and prediction.

Authors:  Tianhong Zhang; Jijun Wang; Tao Chen; Haichun Liu; Renfang Tian; Ranpiao Gan; Wenzuo Xu
Journal:  Gen Psychiatr       Date:  2022-04-28

Review 3.  The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders.

Authors:  E Schwarz; S Bahn
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

4.  Potential metabolite markers of schizophrenia.

Authors:  J Yang; T Chen; L Sun; Z Zhao; X Qi; K Zhou; Y Cao; X Wang; Y Qiu; M Su; A Zhao; P Wang; P Yang; J Wu; G Feng; L He; W Jia; C Wan
Journal:  Mol Psychiatry       Date:  2011-10-25       Impact factor: 15.992

Review 5.  Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia.

Authors:  Sabrina H Ansarey
Journal:  Front Psychiatry       Date:  2021-11-30       Impact factor: 4.157

6.  Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading.

Authors:  Shu-Sen Chang; Chih-Min Liu; Sheng-Hsiang Lin; Hai-Gwo Hwu; Tzung J Hwang; Shi K Liu; Ming H Hsieh; Shi-Chin Guo; Wei J Chen
Journal:  Schizophr Bull       Date:  2008-01-18       Impact factor: 9.306

7.  SKINREMS-A New Method for Assessment of the Niacin Skin Flush Test Response in Schizophrenia.

Authors:  Hanna Karakula-Juchnowicz; Joanna Rog; Piotr Wolszczak; Kamil Jonak; Ewa Stelmach; Paweł Krukow
Journal:  J Clin Med       Date:  2020-06-13       Impact factor: 4.241

8.  Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population.

Authors:  Liya Sun; Xuhan Yang; Jie Jiang; Xiaowen Hu; Ying Qing; Dandan Wang; Tianqi Yang; Chao Yang; Juan Zhang; Ping Yang; Peng Wang; Changqun Cai; Jijun Wang; Lin He; Chunling Wan
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.